RCKT -
Rocket Pharmaceuticals, Inc. Common Stock
| Day |
1m |
10m |
60m |
PreMarket |
Market |
AfterHours |
Gap |
| 2.92 0.04 (1.2%) |
0.0 (0.0%) |
0.0 (0.0%) |
-0.04 (-1.17%) |
-0.08 (-2.74%) |
0.13 (4.42%) |
--- |
-0.08 (-2.74%) |
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
Earnings & Ratios
- Basic EPS:
- -0.62
- Diluted EPS:
- -0.62
- Basic P/E:
- -4.7661
- Diluted P/E:
- -4.7661
- RSI(14) 1m:
- 50.0
- VWAP:
- 2.96
- RVol:
Events
| Period |
Kind |
Movement |
Occurred At |
Related News
ROCKET ALERT: Bragar Eagel & Squire, P.C. is Investigating Rocket Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Oct 23, 2025 22:03
DEADLINE ALERT for RCKT, DDD, TEM, RDDT: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
Aug 11, 2025 16:00
RCKT DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 11 Deadline in Securities Class Action – RCKT
Aug 10, 2025 15:38
Deadline Soon: Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
Aug 08, 2025 16:38
MONDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Aug 07, 2025 23:45
Deadline Alert: Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Aug 07, 2025 18:32
RCKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Aug 06, 2025 20:00
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
Aug 05, 2025 14:00
Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA’s Clinical Hold on Gene Therapy Trial – Hagens Berman
Aug 04, 2025 18:49
מועד אחרון חשוב לתביעה נגד RCKT: רוזן, משרד ארצי מוביל, מעודד משקיעים ב- Rocket Pharmaceuticals, Inc עם הפסדים של יותר מ-100 אלף דולר להבטיח ייעוץ לפני המועד האחרון החשוב של 11 באוגוסט בתביעה ייצוגית בניירות ערך - RCKT
Aug 02, 2025 05:12